China SXT Pharmaceuticals’ (NASDAQ:SXTC) quiet period will expire on Wednesday, February 13th. China SXT Pharmaceuticals had issued 2,546,275 shares in its public offering on January 4th. The total size of the offering was $10,185,100 based on an initial share price of $4.00. During the company’s quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of China SXT Pharmaceuticals stock opened at $5.88 on Friday. China SXT Pharmaceuticals has a twelve month low of $3.62 and a twelve month high of $23.35.

ILLEGAL ACTIVITY WARNING: “China SXT Pharmaceuticals Inc’s Quiet Period Will End on February 13th (NASDAQ:SXTC)” was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/china-sxt-pharmaceuticals-incs-quiet-period-will-end-on-february-13th-nasdaqsxtc/2803980.html.

About China SXT Pharmaceuticals

There is no company description available for China SXT Pharmaceuticals Inc

Featured Story: Price to Earnings Ratio (PE) Basics

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.